1. Home
  2. IMRX vs SRZN Comparison

IMRX vs SRZN Comparison

Compare IMRX & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • SRZN
  • Stock Information
  • Founded
  • IMRX 2008
  • SRZN 2015
  • Country
  • IMRX United States
  • SRZN United States
  • Employees
  • IMRX N/A
  • SRZN N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • SRZN Medicinal Chemicals and Botanical Products
  • Sector
  • IMRX Health Care
  • SRZN Health Care
  • Exchange
  • IMRX Nasdaq
  • SRZN Nasdaq
  • Market Cap
  • IMRX 68.4M
  • SRZN 72.8M
  • IPO Year
  • IMRX 2021
  • SRZN N/A
  • Fundamental
  • Price
  • IMRX $3.38
  • SRZN $8.97
  • Analyst Decision
  • IMRX Strong Buy
  • SRZN Strong Buy
  • Analyst Count
  • IMRX 4
  • SRZN 2
  • Target Price
  • IMRX $13.25
  • SRZN $38.50
  • AVG Volume (30 Days)
  • IMRX 2.9M
  • SRZN 22.8K
  • Earning Date
  • IMRX 08-05-2025
  • SRZN 08-11-2025
  • Dividend Yield
  • IMRX N/A
  • SRZN N/A
  • EPS Growth
  • IMRX N/A
  • SRZN N/A
  • EPS
  • IMRX N/A
  • SRZN N/A
  • Revenue
  • IMRX N/A
  • SRZN $11,638,000.00
  • Revenue This Year
  • IMRX N/A
  • SRZN N/A
  • Revenue Next Year
  • IMRX N/A
  • SRZN N/A
  • P/E Ratio
  • IMRX N/A
  • SRZN N/A
  • Revenue Growth
  • IMRX N/A
  • SRZN N/A
  • 52 Week Low
  • IMRX $1.00
  • SRZN $5.90
  • 52 Week High
  • IMRX $3.87
  • SRZN $18.17
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 69.21
  • SRZN 52.19
  • Support Level
  • IMRX $2.29
  • SRZN $8.38
  • Resistance Level
  • IMRX $3.87
  • SRZN $9.88
  • Average True Range (ATR)
  • IMRX 0.44
  • SRZN 0.75
  • MACD
  • IMRX 0.10
  • SRZN -0.02
  • Stochastic Oscillator
  • IMRX 77.72
  • SRZN 53.33

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Share on Social Networks: